Yunsheng Medical, which was suspended for half a month, announced on the evening of June 28 that the major shareholder Jiuchuan Group intends to transfer its 53.5 million shares (accounting for 15.69% of the total share capital) to Lanrun Assets. The total transaction consideration is 84008.10. After the completion of the share transfer, Lanrun Assets will become the company's largest shareholder.
According to the announcement, the transfer price of the above-mentioned equity was determined to be 15.7 yuan/share through negotiation, and this price was about 14% higher than the stock price of 13.77 yuan before the suspension. After the completion of the share transfer, Jiuchuan Group still established a directional asset management plan with Nanhua Futures, and held 1,395,500 shares of the company through Zhongtai Securities, accounting for 0.4% of the company's total share capital.
Yunsheng Medical stated that the main purpose of the transfer of equity in Lanrun Assets is to effectively integrate resources with the listed company platform, enhance the company's core competitiveness and improve the company's operations. At the same time, Lanrun Assets recognized and optimistic about the future development prospects of Yunsheng Medical. Through this share transfer, it intends to obtain the investment income from the equity appreciation of listed companies.
At the same time, based on the confidence in the future development prospects of Yunsheng Medical and the recognition of the company's value, the Lanrun Assets Plan will not exceed RMB 25/share in Yunsheng Medical within 12 months from June 26, 2016. Under the premise, the increase ratio is not less than 3% and not more than 5%. The increase plan includes Lanrun Assets' commitment to undertake the unfinished 2015 annual shareholding plan of Jiuchuan Group.
The announcement shows that Lanrun Assets was established in March 2014, and its controlling shareholder is Lanrun Group. The actual controllers are Dai Xuebin and Dong Xiang. Lanrun Group is a large-scale integrated industrial group with real estate development as its core business and an important part of property management, energy and chemical industries. As of the first quarter of 2016, Lanrun Group's land reserves, accumulated development volume, and accumulated management properties were among the top in Sichuan's housing enterprises.
Lanrun Assets said in the announcement that after becoming the largest shareholder of Yunsheng Medical, it will take the opportunity to divest the company's original badly operated assets and inject medical-related quality assets. However, as of now, the above-mentioned asset divestiture and injection plan is still in the due diligence and preparation stage, and further argumentation and improvement are needed.
Butyl Rubber Stopper For Antibiotic Bottle
Our butyl rubber stoppers for antibiotic bottles are produced by a series of advanced technics during the production such as vulcanization, mould cutting, washing and packaging .These procedures are set due to the GMP standard. Also we have a full set of quality control system which ensures us to offer suitable products at best prices.After the goods are finished, we will use a full automatic washing line to clean the goods, and our washing line has a powerful vibrating and wash-blowing fuction. Our products have a good compability with drugs. If you are looking for an excellent and loyal cooperator , pls feel free to contact us.
Butyl Rubber Stopper For Antibiotic Bottle,Rubber Stopper,Stopper For Antibiotic Bottle,Sterilized Butyl Rubber Stoppers
SUZHOU CRH PHARMACEUTICAL TECHNOLOGY CO.,LTD , https://www.crh-health.com